Ikapharmindo Putramas Tbk. Net Assets

Latest as of June 2025: Rp236.96 Billion IDR ≈ $13.89 Million USD

Ikapharmindo Putramas Tbk. net assets. Based on the latest financial reports, Ikapharmindo Putramas Tbk. (IKPM) has net assets worth Rp236.96 Billion IDR (≈ $13.89 Million USD) as of June 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Rp476.89 Billion ≈ $27.94 Million USD) and total liabilities (Rp239.93 Billion ≈ $14.06 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore Ikapharmindo Putramas Tbk. equity growth rate to track the company's year-over-year net asset growth rate.

Key Net Assets Metrics

Metric	Value
Current Net Assets	Rp236.96 Billion
% of Total Assets	49.69%
Annual Growth Rate	18.01%
5-Year Change	N/A
10-Year Change	N/A
Growth Volatility	18.96

Net Assets of Ikapharmindo Putramas Tbk. (2022–2024)

Net assets of Ikapharmindo Putramas Tbk. from 2022 to 2024. This chart illustrates how Ikapharmindo Putramas Tbk.'s net assets have evolved over time, based on quarterly financial data. See Ikapharmindo Putramas Tbk. balance sheet independence to measure how much of total assets are equity-financed.

Annual Net Assets for Ikapharmindo Putramas Tbk. (2022–2024)

The table below shows the annual net assets of Ikapharmindo Putramas Tbk. from 2022 to 2024. For live market cap and overall valuation, see IKPM stock market capitalisation.

Year	Net Assets	Change
2024-12-31	Rp246.12 Billion ≈ $14.42 Million	+0.58%
2023-12-31	Rp244.71 Billion ≈ $14.34 Million	+38.49%
2022-12-31	Rp176.70 Billion ≈ $10.35 Million	--

Equity Component Analysis

This analysis shows how different components contribute to Ikapharmindo Putramas Tbk.'s total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

Retained earnings have decreased by 28.5% over the analyzed period, potentially due to dividend distributions or operating losses.

Ikapharmindo Putramas Tbk. Net Assets Breakdown (December 2024)

Ikapharmindo Putramas Tbk. net assets breakdown by equity component as of December 2024.

Component	Amount	Percentage
Retained Earnings	Rp45.59 Billion	18.52%
Common Stock	Rp168.47 Billion	68.45%
Other Components	Rp32.07 Billion	13.03%
Total Equity	Rp246.12 Billion	100.00%

Ikapharmindo Putramas Tbk. Competitors by Market Cap

The table below lists competitors of Ikapharmindo Putramas Tbk. ranked by their market capitalization.

Company	Market Cap
DeepMarkit Corp. NASDAQ:MKTSF	$13.63 Million
Magnum Mining and Exploration Ltd AU:MGU	$13.64 Million
Huge Group Ltd JSE:HUG	$13.65 Million
Swoop Holdings Ltd AU:SWP	$13.65 Million
J D Wetherspoon PLC LSE:JDW	$13.62 Million
Good Times Restaurants Inc NASDAQ:GTIM	$13.62 Million
CMX GOLD+SILVER CORP. F:6GS	$13.61 Million
FIPP S.A. PA:FIPP	$13.61 Million

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Ikapharmindo Putramas Tbk.'s equity between the two most recent reporting periods.

Equity Growth Insights

From 2023 to 2024, total equity changed from 244,711,674,310 to 246,124,886,180, a change of 1,413,211,870 (0.6%).
Net income of 5,014,949,520 contributed positively to equity growth.
Dividend payments of 3,790,490,630 reduced retained earnings.

Equity Change Factors (2023 to 2024)

Factor	Impact	Contribution
Net Income	Rp5.01 Billion	+2.04%
Dividends Paid	Rp3.79 Billion	-1.54%
Other Changes	Rp188.75 Million	+0.08%
Total Change	Rp-	0.58%

Book Value vs Market Value Analysis

This analysis compares Ikapharmindo Putramas Tbk.'s book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

Current price-to-book ratio: 0.94x
The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
The price-to-book ratio has decreased from 1.32x to 0.94x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date	Book Value per Share	Market Price	P/B Ratio
2022-12-31	Rp104.89	Rp138.00	x
2023-12-31	Rp145.26	Rp138.00	x
2024-12-31	Rp146.10	Rp138.00	x

Capital Efficiency Dashboard

This dashboard shows how efficiently Ikapharmindo Putramas Tbk. utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

Current Return on Equity (ROE): 2.04%
The company may be facing challenges in efficiently utilizing shareholder equity.
DuPont Analysis Breakdown:
• Net Profit Margin: 1.22%
• Asset Turnover: 0.84x
• Equity Multiplier: 2.00x
Recent ROE (2.04%) is below the historical average (5.90%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year	Return on Equity	Net Profit Margin	Asset Turnover	Equity Multiplier	Economic Value Added
2022	9.38%	4.16%	1.03x	2.19x	Rp-1.09 Billion
2023	6.27%	3.48%	0.95x	1.89x	Rp-9.13 Billion
2024	2.04%	1.22%	0.84x	2.00x	Rp-19.60 Billion

Industry Comparison

This section compares Ikapharmindo Putramas Tbk.'s net assets metrics with peer companies in the Pharmaceutical Retailers industry.

No peer company data available for comparison.

About Ikapharmindo Putramas Tbk.

JK:IKPM Indonesia Pharmaceutical Retailers

Market Cap

$13.62 Million

Rp232.48 Billion IDR

Market Cap Rank

#26129 Global

#562 in Indonesia

Share Price

Rp138.00

Change (1 day)

+2.22%

52-Week Range

Rp134.00 - Rp280.00

All Time High

Rp324.76